Literature DB >> 24914376

Dual-priming oligonucleotide-based multiplex PCR using tissue samples in rapid urease test in the detection of Helicobacter pylori infection.

Woo Chul Chung1, Sung Hoon Jung1, Jung Hwan Oh1, Tae Ho Kim1, Dae Young Cheung1, Byung Wook Kim1, Sung Soo Kim1, Jin Il Kim1, Eun Young Sin1.   

Abstract

AIM: To investigate whether tissue samples processed by the rapid urease test (RUT) kit are suitable for dual-priming oligonucleotide-based multiplex polymerase chain reaction (DPO-PCR) to detect Helicobacter pylori (H. pylori).
METHODS: A total of 54 patients with specific gastrointestinal symptom were enrolled in this study. During endoscopy, gastric biopsy specimens were taken for histology, RUT, and DPO-PCR. DPO-PCR was performed on gastric biopsy samples and tissue samples that were analyzed by RUT at 2 separate institutes. In detecting H. pylori, the concordance rate of the DPO-PCR tests between the tissue samples that had been submitted to RUT and the gastric biopsy samples was investigated.
RESULTS: H. pylori co-occurred with 76.0% (19/25) of gastric ulcers, 64.3% (9/14) of duodenal ulcers, and 33.3% (4/12) of gastritis cases. H. pylori infection was found in 100% (3/3) of the patients with both gastric and duodenal ulcers. Overall, H. pylori was detected in 35 of 54 (64.8%) patients. The diagnostic sensitivities of histology, RUT, and DPO-PCR were 85.7% (30/35), 74.3% (26/35), and 97.1% (34/35), respectively (P = 0.02). The positive predictive value (PPV) of DPO-PCR was 94.4%, whereas the negative predictive value (NPV) was 94.7%. In the rapid urease test (CLOtest)-negative cases, the frequency of positive DPO-PCR and histologic results was 20.0% (7/35). The concordance rate of the DPO-PCR tests between the tissue samples from the RUT kit and the gastric biopsy samples was 94.4% (51/54). The rate of DPO-PCR and silver stain positivity in the RUT-negative cases was 20.0% (7/35).
CONCLUSION: In diagnosing H. pylori infection, DPO-PCR can be performed on tissue samples that have been processed by the RUT kit. Particularly, in patients with RUT-negative results, DPO-PCR on these tissue samples could be helpful in detecting of H. pylori infection.

Entities:  

Keywords:  Diagnosis; Dual-priming oligonucleotide-based multiplex polymerase chain reaction; Helicobacter pylori

Mesh:

Substances:

Year:  2014        PMID: 24914376      PMCID: PMC4047340          DOI: 10.3748/wjg.v20.i21.6547

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

3.  Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance.

Authors:  Hyun Jeong Lee; Jin Il Kim; Dae Young Cheung; Tae Ho Kim; Eun Jung Jun; Jung-Hwan Oh; Woo Chul Chung; Byung-Wook Kim; Sung Soo Kim; Soo-Heon Park; Jae Kwang Kim
Journal:  J Infect Dis       Date:  2013-06-24       Impact factor: 5.226

4.  Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days.

Authors:  Yuan Li; Emiko Rimbara; Selvi Thirumurthi; Alba Trespalacios; Rita Reddy; Saman Sabounchi; Taraq Assed Attumi; David Yates Graham
Journal:  J Dig Dis       Date:  2012-01       Impact factor: 2.325

5.  Use of different PCR primers and gastric biopsy tissue from CLO test for the detection of Helicobacter pylori.

Authors:  Sukanya Linpisarn; Chuchart Koosirirat; Kunrunya Prommuangyong; Warissara Suwan; Nirush Lertprasertsuke; Kannika Phornphutkul
Journal:  Southeast Asian J Trop Med Public Health       Date:  2005-01       Impact factor: 0.267

6.  Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea.

Authors:  J J Kim; R Reddy; M Lee; J G Kim; F A El-Zaatari; M S Osato; D Y Graham; D H Kwon
Journal:  J Antimicrob Chemother       Date:  2001-04       Impact factor: 5.790

7.  Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Authors:  J Versalovic; D Shortridge; K Kibler; M V Griffy; J Beyer; R K Flamm; S K Tanaka; D Y Graham; M F Go
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 8.  Helicobacter pylori detection and antimicrobial susceptibility testing.

Authors:  Francis Mégraud; Philippe Lehours
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

9.  Detection of primary clarithromycin resistance of Helicobacter pylori and association between cagA (+) status and clinical outcome.

Authors:  Erkan Yula; Toğrul Nagiyev; Ozlem Aycan Kaya; Melek Inci; M Murat Celik; Fatih Köksal
Journal:  Folia Microbiol (Praha)       Date:  2012-09-06       Impact factor: 2.099

10.  Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene.

Authors:  Jong-Yoon Chun; Kyoung-Joong Kim; In-Taek Hwang; Yun-Jee Kim; Dae-Hoon Lee; In-Kyoung Lee; Jong-Kee Kim
Journal:  Nucleic Acids Res       Date:  2007-02-07       Impact factor: 16.971

View more
  8 in total

Review 1.  Helicobacter pylori infection in children: an overview of diagnostic methods.

Authors:  Parisa Sabbagh; Mostafa Javanian; Veerendra Koppolu; VeneelaKrishna Rekha Vasigala; Soheil Ebrahimpour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-07       Impact factor: 3.267

Review 2.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

Review 3.  Diagnosis of Helicobacter pylori infection: Current options and developments.

Authors:  Yao-Kuang Wang; Fu-Chen Kuo; Chung-Jung Liu; Meng-Chieh Wu; Hsiang-Yao Shih; Sophie S W Wang; Jeng-Yih Wu; Chao-Hung Kuo; Yao-Kang Huang; Deng-Chyang Wu
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

4.  Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication.

Authors:  Young Woon Chang; Ga Young Shin; Jung-Wook Kim; Jin-Chang Moon; Eun Jee Chang; Chi Hyuk Oh; Jae-Young Jang
Journal:  Dig Dis Sci       Date:  2021-03-23       Impact factor: 3.199

5.  Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for Helicobacter pylori.

Authors:  Sang Yoon Kim; Jae Myung Park; Chul-Hyun Lim; Hye Ah Lee; Ga-Yeong Shin; Younghee Choe; Yu Kyung Cho; Myung-Gyu Choi
Journal:  Gut Liver       Date:  2021-07-15       Impact factor: 4.519

6.  Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial.

Authors:  Youn I Choi; Jun Won Chung; Dong Kyun Park; Kyoung Oh Kim; Kwang An Kwon; Yoon Jae Kim; Ja Young Seo
Journal:  World J Gastroenterol       Date:  2019-12-14       Impact factor: 5.742

7.  Simultaneous Detection of Bovine Rotavirus, Bovine Parvovirus, and Bovine Viral Diarrhea Virus Using a Gold Nanoparticle-Assisted PCR Assay With a Dual-Priming Oligonucleotide System.

Authors:  Mengmeng Wang; Yue Yan; Ruichong Wang; Li Wang; Han Zhou; Yijing Li; Lijie Tang; Yigang Xu; Yanping Jiang; Wen Cui; Xinyuan Qiao
Journal:  Front Microbiol       Date:  2019-12-12       Impact factor: 5.640

8.  Multiple Genetic Analysis System-Based Antibiotic Susceptibility Testing in Helicobacter pylori and High Eradication Rate With Phenotypic Resistance-Guided Quadruple Therapy.

Authors:  Fangyuan Dong; Danian Ji; Renxiang Huang; Fan Zhang; Yiqin Huang; Ping Xiang; Mimi Kong; Li Nan; Xianping Zeng; Yong Wu; Zhijun Bao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.